Myeloproliferative Neoplasm
Showing NaN - NaN of 13
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CIML NK
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 6, 2023
Project: Every Child for Younger Patients With Cancer
Recruiting
- Carcinoma In Situ
- +10 more
- Cytology Specimen Collection Procedure
- Medical Chart Review
-
Birmingham, Alabama
- +240 more
Oct 19, 2022
Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)
Recruiting
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- +3 more
-
Gilbert, Arizona
- +14 more
Apr 20, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)
Completed
- Myelodysplastic Syndrome
- +3 more
-
Tampa, Florida
- +5 more
Jan 14, 2022
Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- Azacitidine
- +2 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2021
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Myeloproliferative Tumor, Recurrent Acute Lymphoblastic Leukemia Trial
Completed
- Allogeneic Hematopoietic Stem Cell Transplant Recipient
- +10 more
- Ipilimumab
- +2 more
-
Duarte, California
- +12 more
Jun 23, 2021
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Not yet recruiting
- Pyruvate Kinase Deficiency
- +10 more
- Blood Draw
-
Boston, MassachusettsMassachusetts General Hospital
May 21, 2021
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Withdrawn
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
- +2 more
-
Duarte, California
- +2 more
Nov 19, 2018